Loading stock data...

Chemo Pharma Laboratories Limited

BSE: CHEMOPH

BSE
123.00 2.40 (1.99%)

Prev Close

120.6

Open Price

118.2

Volume

799

Today Low / High

118.2 / 123

52 WK Low / High

63.05 / 152

Range

117 - 129

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 123, reflecting a change of 2.4 (1.99005%). The expected target range on the BSE is 117 - 129. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

13 Jun 118.20 4.06%
12 Jun 125.00 -3.52%
11 Jun 123.00 0.00%
10 Jun 124.85 0.52%
09 Jun 126.00 0.08%
06 Jun 130.90 -1.95%
05 Jun 130.95 0.00%
04 Jun 138.50 -3.54%
03 Jun 136.30 0.00%
02 Jun 139.05 0.00%
30 May 141.85 0.00%
29 May 144.70 0.00%
28 May 148.65 -0.67%
27 May 152.00 -0.89%
26 May 138.45 5.45%
23 May 141.70 -1.83%
22 May 136.20 -0.70%
21 May 118.10 10.25%
20 May 121.15 2.35%
19 May 131.90 -3.75%

Chemo Pharma Laboratories Limited Graph

Chemo Pharma Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Chemo Pharma Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 123.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 123.00 124.23 111.81 - 136.65
125.46 100.37 - 150.55
126.69 88.68 - 164.70
Bearish Scenario 123.00 121.77 109.59 - 133.95
120.54 96.43 - 144.65
119.31 83.52 - 155.10

Overview of Chemo Pharma Laboratories Limited

ISIN

INE320M01019

Industry

Medical - Pharmaceuticals

Vol.Avg

1,596

Market Cap

184,500,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

207.95

DCF

-85

Financial Ratios Every Investor Needs

Stock Rating Details for CHEMOPH

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 1.84 Cr 0.00 Cr 1.84 Cr 1.0000 0.00 Cr 0.17 Cr 1.64 Cr 1.20 Cr 8.00 1.65 Cr 0.6530
2023-03-31 0.30 Cr 0.00 Cr 0.29 Cr 0.9982 0.00 Cr 0.03 Cr 0.50 Cr 0.05 Cr 0.32 0.10 Cr 0.1603
2022-03-31 0.79 Cr 0.00 Cr 0.79 Cr 0.9989 0.00 Cr 0.12 Cr 0.25 Cr 0.56 Cr 3.73 0.27 Cr 0.7098
2021-03-31 0.55 Cr 0.00 Cr 0.55 Cr 0.9957 0.00 Cr 0.03 Cr 0.37 Cr 0.25 Cr 1.67 0.39 Cr 0.4561
2020-03-31 1.00 Cr 0.00 Cr 1.00 Cr 0.9983 0.00 Cr 0.00 Cr 0.51 Cr 0.42 Cr 2.77 0.00 Cr 0.4165

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 0.61 Cr 13.02 Cr 0.21 Cr 12.8024 Cr 0.00 Cr -0.61 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 4.40 Cr 0.1781 Cr
2023-03-31 0.56 Cr 11.62 Cr 0.02 Cr 11.6020 Cr 0.00 Cr -0.56 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr -2.47 Cr 0.0200 Cr
2022-03-31 0.69 Cr 11.66 Cr 0.11 Cr 11.5547 Cr 0.00 Cr -0.69 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr -2.56 Cr 0.1083 Cr
2021-03-31 2.17 Cr 11.05 Cr 0.06 Cr 10.9948 Cr 0.00 Cr -2.17 Cr 0.00 Cr 0.05 Cr 0.00 Cr 0.00 Cr -8.66 Cr 0.0584 Cr
2020-03-31 8.81 Cr 10.97 Cr 0.22 Cr 4.1032 Cr 0.00 Cr -8.81 Cr 0.00 Cr 0.07 Cr 0.00 Cr 0.00 Cr 0.02 Cr 0.2210 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 0.7236 Cr -0.5248 Cr -0.1489 Cr 0.7236 Cr 0.0499 Cr 0.6058 Cr 0.0000 Cr 1.2004 Cr -0.1489 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -0.6834 Cr 0.6297 Cr -0.0763 Cr -0.6834 Cr -0.1300 Cr 0.5558 Cr 0.0000 Cr 0.0732 Cr -0.0763 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -0.3286 Cr 0.9677 Cr -2.1243 Cr -0.3286 Cr -1.4852 Cr 0.6859 Cr 0.0000 Cr 0.3649 Cr -2.1243 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 -0.4083 Cr -0.1857 Cr 1.9568 Cr -0.4083 Cr 1.3627 Cr 2.1711 Cr 0.0000 Cr 0.3107 Cr 1.9568 Cr 0.0000 Cr 0.0000 Cr
2020-03-31 4.8323 Cr 1.0100 Cr 0.0000 Cr 4.8323 Cr 5.8423 Cr 8.8084 Cr 0.0000 Cr 0.4152 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-06-30 0.30 Cr 0.00 Cr 0.30 Cr 1.0000 0.25 Cr 0.25 Cr 1.64 0.25 Cr 0.8171
2024-03-31 0.25 Cr 0.00 Cr 0.25 Cr 1.0000 0.15 Cr -0.29 Cr -1.94 0.15 Cr -1.1812
2023-12-31 0.70 Cr 0.00 Cr 0.70 Cr 1.0000 0.68 Cr 0.68 Cr 4.51 0.68 Cr 0.9627
2023-09-30 0.46 Cr 0.00 Cr 0.46 Cr 1.0000 0.44 Cr 0.44 Cr 2.93 0.44 Cr 0.9554
2023-06-30 0.43 Cr 0.00 Cr 0.43 Cr 1.0000 0.38 Cr 0.38 Cr 2.51 0.38 Cr 0.8763

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 1.25 Cr 5.68 Cr 6.94 Cr 0.00 Cr 0.00 Cr 6.95 Cr 0.02 Cr 13.70 Cr 0.04 Cr
2024-06-30 -6.11 Cr 12.21 Cr 6.11 Cr 0.00 Cr 0.00 Cr 6.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.61 Cr 5.50 Cr 6.11 Cr 0.00 Cr 0.00 Cr 6.25 Cr 0.02 Cr 13.02 Cr 0.21 Cr
2023-12-31 -5.99 Cr 11.97 Cr 5.99 Cr 0.00 Cr 0.00 Cr 5.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.49 Cr 5.80 Cr 6.29 Cr 0.00 Cr 0.00 Cr 6.36 Cr 0.02 Cr 12.43 Cr 0.01 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 0.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-06-30 0.38 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹880.60 ₹105,402,386,698.00 ₹101,527.00

Key Executives

Company Secretary & Compliance Officer
Bhawna Rajput

Gender: Not Specified

Year Born:

FAQs about Chemo Pharma Laboratories Limited

Who is the CEO of the company?

The CEO is Bhawna Rajput.

What is the current market price of the stock?

The current price is ₹123.00.

What is the 52-week price range?

The range is ₹63.05-152.

What is the market capitalization of the company?

The market capitalization is ₹18.45 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 29.30.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Chemo Pharma Laboratories Limited (ISIN: INE320M01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹18.45 crores and an average daily volume of 1,596 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack